The MGH Cardiac Arrhythmia service provides the highest quality care to patients with cardiac arrhythmias while training future leaders in the field and carrying out essential basic and clinical research to advance the field.
- Centers & Specialties
- Clinical Interests
- Atrial fibrillation
- Catheter ablation for cardiac arrhythmias
- Ventricular arrhythmias
- Long QT and Brugada syndromes
- Unexplained syncope
- Antiarrhythmic drugs
- Clinical cardiac electrophysiology
- Cardiac arrhythmia
- Medical Education
- MD, Harvard Medical School
- Residency, Beth Israel Deaconess Medical Center
- Fellowship, Massachusetts General Hospital|Fellowship, U.S. Public Health Service Hospital
- Board Certifications
- Cardiovascular Disease
- Internal Medicine
- Clinical Cardiac Electrophysiology
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - other
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
Dr. Jeremy Ruskin is Founder and Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Dr. Ruskin received his undergraduate degree from Tufts University and his medical degree from Harvard Medical School. He completed his residency in Internal Medicine at Beth Israel Hospital in Boston and his fellowship in Cardiovascular Disease at the Massachusetts General Hospital. He received his training in clinical cardiac electrophysiology at the USPHS Hospital in Staten Island, New York under the mentorship of Dr. Anthony Damato.
In 1978, Dr. Ruskin founded the first cardiac arrhythmia service and clinical electrophysiology laboratory in New England and one of the first such services in the United States. As founder and director of the MGH Fellowship Training Program in Clinical Cardiac Electrophysiology, he has been responsible for the training of more than 110 fellows in the subspecialty of cardiac arrhythmias over the past 36 years, many of whom are in leadership positions at academic centers throughout the world. His major research interests include the mechanisms and management of atrial fibrillation, new antiarrhythmic drugs and innovative technologies for catheter ablation of atrial fibrillation, the mechanisms and prevention of ventricular arrhythmias and sudden cardiac death, risk stratification for sudden death, the role of arrhythmia control devices in the prevention of sudden cardiac death, the proarrhythmic effects of cardiac and non-cardiac drugs and cardiac safety issues in new drug and device development. He is an author of more than 400 original scientific publications, chapters, reviews, and monographs. Dr. Ruskin is the recipient of the 1997 Michel Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology and the 2002 Heart Rhythm Society Pioneer in Pacing and Electrophysiology Award.
- Research Summary
- The MGH Cardiac Arrhythmia Service physicians have made important research contributions in a number of areas including the management of survivors of out of hospital cardiac arrest, the development of experimental models for the study of ischemia and infarct-related ventricular arrhythmias, the role of ventricular arrhythmias in the occurrence of unexplained syncope in patients with structural heart disease, the proarrhythmic effects of antiarrhythmic drugs, new energy sources for catheter ablation of atrial fibrillation including cryothermal and laser ablation, the development of advanced image integration techniques to guide mapping and ablation of atrial fibrillation and ventricular tachycardia and techniques for optimizing response rates in patients receiving cardiac resynchronization devices for the treatment of congestive heart failure. All of this work has been accomplished in an environment in which dedication to optimal clinical care and patient safety through a disciplined and scholarly approach to the practice of medicine have been and remain the highest priorities of the service.
See Pub Med link
Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present insights and opinions on methods for treating refractory heart failure, genetically determined arrhythmias and atrial fibrillation in an integrated, multispecialty program.
Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present a dynamic symposium on systemic cardiovascular disease.
The Mass General Institute for Heart, Vascular, and Stroke Care integrates services to accelerate advances in stroke-related atrial fibrillation research and patient care.
55 Fruit Street
Boston MA, 02114-2696